- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Glimepiride
Total 236 results
-
Eli Lilly and CompanyWithdrawnDiabetes Mellitus, Type 2United States, Spain, Poland, Austria, Germany, Czech Republic, Russian Federation
-
Merck Sharp & Dohme LLCCompleted
-
Kaiser PermanentePatient-Centered Outcomes Research Institute; Henry Ford Health System; HealthPartners... and other collaboratorsRecruitingCardiovascular Diseases | Type 2 Diabetes MellitusUnited States
-
Vanderbilt UniversityCompleted
-
Yonsei UniversityNot yet recruitingDiabetes Mellitus | Sodium-Glucose Transporter 2 Inhibitors | Cellular SenescenceKorea, Republic of
-
PfizerCompletedDiabetes Mellitus, Type 2Taiwan, United States, Hungary, Canada, Slovakia, India, Bulgaria
-
Yonsei UniversityCompletedType2 Diabetes MellitusKorea, Republic of
-
Hannover Medical SchoolBoehringer IngelheimTerminated
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Austria, Canada, Colombia, Czech Republic, Finland, Hong Kong, India, Italy, Malaysia, Mexico, Netherlands, Norway, Philippines, Portugal, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, United...
-
Boehringer IngelheimCompleted
-
University Hospital, Gentofte, CopenhagenNovo Nordisk A/S; University of CopenhagenCompletedMaturity-onset Diabetes of the YoungDenmark
-
VA Office of Research and DevelopmentNational Eye Institute (NEI); SmithKline BeechamCompletedType 2 Diabetes MellitusUnited States, Puerto Rico
-
Kurume UniversityUnknownEffects of the DPP-4 Inhibitors or SGLT2 Inhibitors on the Protective Actions for Diabetic ComplicationsJapan
-
Gulf Regional Research & Educational Services, LLCUnknownMechanistic Study of the Systolic Blood Pressure Lowering Effect of Dapagliflozin in Type 2 DiabetesDiabetes Mellitus Type 2United States
-
Peking Union Medical College HospitalChinese Academy of SciencesUnknown
-
SanofiCompleted
-
SanofiCompletedDiabetes Mellitus, Type 2Brazil, Thailand, Slovakia, Poland, Netherlands, Kuwait, Mexico, Korea, Republic of, Czech Republic, Egypt, France, Italy, Romania, Russian Federation, Sweden, Switzerland, United Arab Emirates
-
Merck Sharp & Dohme LLCCompleted
-
University of MichiganAstraZenecaCompletedCardiovascular Diseases | Type2 DiabetesUnited States
-
Novartis PharmaceuticalsCompletedType II Diabetes MellitusGermany
-
Ohio UniversityWestern University of Health SciencesCompletedType 2 DiabetesUnited States
-
SanofiCompletedDiabetes Mellitus, Type 2Russian Federation, United States, United Kingdom
-
Seoul National University HospitalCompletedDiabetes Mellitus, Non-Insulin-DependentKorea, Republic of
-
ikfe-CRO GmbHNovartis Pharmaceuticals; IKFE Institute for Clinical Research and DevelopmentUnknown
-
Merck Sharp & Dohme LLCPfizerCompleted
-
Kurume UniversityCompletedType 2 Diabetes Mellitus | Atherosclerosis | Impaired Glucose ToleranceJapan
-
Merck Sharp & Dohme LLCCompleted
-
Novartis PharmaceuticalsTerminated
-
Novartis PharmaceuticalsCompletedEfficacy and Safety of Vildagliptin in Combination With Glimepiride in Patients With Type 2 DiabetesDiabetes Mellitus, Type 2United States
-
University of LeicesterUniversity Hospital BirminghamCompletedDiabetes Mellitus, Type 2United Kingdom
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2United States, Poland, Germany, Israel, Bulgaria, Costa Rica, India, Romania, Ukraine, Finland, Korea, Republic of, Canada, Philippines, Russian Federation, Argentina, Norway, Denmark, Slovakia, Mexico, Puerto Rico
-
Astellas Pharma IncCompletedType 2 Diabetes MellitusJapan
-
Brigham and Women's HospitalCompleted
-
Merck Sharp & Dohme LLCCompleted
-
University of Campania "Luigi Vanvitelli"Unknown
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2France, Germany, Slovakia, Sweden, Ukraine, United Kingdom
-
Japan Association for Diabetes Education and CareMerck Sharp & Dohme LLCCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
Gilead SciencesCompletedType 2 Diabetes MellitusUnited States, Russian Federation, Thailand, Serbia, Poland, Hungary, Malaysia, South Africa, Ukraine, Czech Republic, Romania, Slovakia
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Australia, Canada, Finland, Israel, Japan, New Zealand, Slovakia, Sweden
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes MellitusSweden, Italy, United Kingdom, Finland, Norway, Mexico, Austria, Denmark, Germany, Hungary, Greece, France, Spain
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesCzech Republic, Korea, Republic of, Hungary, Poland, Ukraine, Philippines, Thailand
-
Merck Sharp & Dohme LLCPfizerCompleted
-
SanofiCompletedDiabetes Mellitus, Type 2France, Germany, Netherlands, Spain, Sweden, Switzerland, United Kingdom, Finland, Italy, Austria
-
Merck Sharp & Dohme LLCPfizerCompletedType 2 Diabetes Mellitus
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Canada, Mexico, Philippines, Romania, Russian Federation, Ukraine
-
Kansai Electric Power HospitalSaiseikai Noe Hospital OsakaCompletedDiabetes Mellitus, Type 2Japan
-
Dokkyo Medical UniversityMerck Sharp & Dohme LLCUnknown
-
Chungbuk National University HospitalCompleted